BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 20571622)

  • 1. Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.
    Matesanz AI; Joie C; Souza P
    Dalton Trans; 2010 Aug; 39(30):7059-65. PubMed ID: 20571622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bis(thiosemicarbazones) of the 3,5-diacetyl-1,2,4-triazol series and their platinum(II) complexes: chemistry, antiproliferative activity and preliminary nephrotoxicity studies.
    Matesanz AI; Hernández C; Rodríguez A; Souza P
    Dalton Trans; 2011 Jun; 40(21):5738-45. PubMed ID: 21519595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palladium and platinum 3,5-diacetyl-1,2,4-triazol bis(thiosemicarbazones): chemistry, cytotoxic activity and structure-activity relationships.
    Matesanz AI; Souza P
    J Inorg Biochem; 2007 Feb; 101(2):245-53. PubMed ID: 17097146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New palladium and platinum complexes with bioactive 3,5-diacetyl-1,2,4-triazol bis(4-cyclohexyl thiosemicarbazone) ligand: chemistry, antiproliferative activity and preliminary toxicity studies.
    Matesanz AI; Perles J; Souza P
    Dalton Trans; 2012 Oct; 41(40):12538-47. PubMed ID: 22955178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5-diacetyl-1,2,4-triazol bis(4N-substituted thiosemicarbazone) palladium(II) complexes: synthesis, structure, antiproliferative activity and low toxicity on normal kidney cells.
    Matesanz AI; Hernández C; Rodríguez A; Souza P
    J Inorg Biochem; 2011 Dec; 105(12):1613-22. PubMed ID: 22071086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
    Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
    Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
    Matesanz AI; Leitao I; Souza P
    J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cyclopalladated and coordination palladium and platinum complexes derived from alpha-diphenyl ethanedione bis(thiosemicarbazones): structural studies and cytotoxic activity against human A2780 and A2780cisR carcinoma cell lines.
    Matesanz AI; Souza P
    J Inorg Biochem; 2007 Oct; 101(10):1354-61. PubMed ID: 17640735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
    Starha P; Trávnícek Z; Popa I
    J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
    Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
    J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2].
    Grabner S; Modec B; Cemazar M; Bukovec N
    J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
    Zák F; Turánek J; Kroutil A; Sova P; Mistr A; Poulová A; Mikolin P; Zák Z; Kasná A; Záluská D; Neca J; Sindlerová L; Kozubík A
    J Med Chem; 2004 Jan; 47(3):761-3. PubMed ID: 14736257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands.
    Ravera M; Gabano E; Sardi M; Ermondi G; Caron G; McGlinchey MJ; Müller-Bunz H; Monti E; Gariboldi MB; Osella D
    J Inorg Biochem; 2011 Mar; 105(3):400-9. PubMed ID: 21421126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
    Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
    Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.